TRXB

10.3156.12%
MJ

Marion Johnston Erwin

Chairman & CEO

Mr. Marion Johnston Erwin Jr. has been the Chief Executive Officer of TRex Bio, Inc. since May 2021 and serves as its Chairman since October 2026 and serves as its Director since May 2021 and served as its Chief Financial Officer and Secretary. Mr. Erwin joined TRexBio in May 2021. He is a seasoned industry veteran with experience in business development, venture investment, collaboration management and clinical and regulatory development. Most recently, he was Vice President of Corporate Business Development – Lilly New Ventures at Eli Lilly and Company. Mr. Erwin spent 36 years at Lilly. From 2002 to 2014, he led the clinical team which made global regulatory submissions for the brands of Evista and Forteo. Under his leadership, both brands were approved in more than 80 countries and reached “blockbuster” status of greater than 1 Billion in worldwide sales each. Starting in 2014 and until his retirement in 2021, he led Lilly New Ventures – Lilly’s internal venture capital investment team. During his tenure, the invested capital grew more than five times and was cash-on-cash positive for seven consecutive years. Given the strategic nature of Lilly’s investments, they acquired >10 companies and established collaborations with >20 companies where Mr. Erwin was part of the founding investment team, investor or board member. Mr. Erwin received his BAS from Oregon State University.

Positions